Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
- 20 September 2002
- journal article
- Published by Elsevier BV in Epilepsy Research
- Vol. 51 (1-2), 31-71
- https://doi.org/10.1016/s0920-1211(02)00106-7
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Talampanel, a Novel Noncompetitive AMPA Antagonist, is Neuroprotective after Traumatic Brain Injury in RatsJournal of Neurotrauma, 2001
- Visual Function is Stable in Patients Who Continue Long‐Term Vigabatrin Therapy: Implications for Clinical Decision MakingEpilepsia, 2001
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Prospective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory SeizuresEpilepsia, 2000
- Gabapentin as Add‐On Therapy in Children with Refractory Partial Seizures: A 12‐Week, Multicentre, Double‐Blind, Placebo‐Controlled StudyEpilepsia, 1999
- Structure-Pharmacokinetic-Pharmacodynamic Relationships of yV-Alkyl Derivatives of the New Antiepileptic Drug Valproyl GlycinamideEpilepsia, 1999
- Safety of intravenous valproateAnnals of Neurology, 1995
- Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. II. Modulation of High‐Voltage‐Activated Calcium CurrentsEpilepsia, 1995
- Oxcarbazepine: Mechanisms of ActionEpilepsia, 1994
- Comparison of the effect of the GABA uptake blockers, tiagabine and nipecotic acid, on inhibitory synaptic efficacy in hippocampal CA1 neuronesNeuroscience Letters, 1992